A Phase 2, Randomized, Double-blind, Placebo-Controlled Efficacy, Pharmacokinetics and Safety Study of CA-008 in Subjects Undergoing Total Knee Arthroplasty
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2019
Price : $35 *
At a glance
- Drugs CA-008 (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Concentric Analgesics
- 22 Jul 2019 Status changed from active, no longer recruiting to completed.
- 23 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 24 Jan 2019 Planned number of patients changed from 66 to 200.